Stockreport

Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel

Qualigen Therapeutics, Inc.  (QLGN) 
PDF CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company [Read more]